Modulation effect of filamentous phage on alpha-synuclein aggregation.

Area of Science:

• Biochemistry
• Neuroscience
• Molecular Biology

Background:

• Amyloid fibril formation from soluble proteins like alpha-synuclein is central to neurodegenerative diseases, including Parkinson's disease (PD).
• Filamentous phages share structural similarities with amyloid fibrils and are well-characterized at genetic and structural levels.

Purpose of the Study:

• To investigate the effect of filamentous phages on alpha-synuclein (AS) aggregation in vitro and in a cellular model of Parkinson's disease.
• To explore the potential of phage-mediated delivery for therapeutic intervention in Parkinson's disease.

Main Methods:

• Utilized the f88 phage display system to present a cyclic RGD peptide for cellular internalization.
• Introduced phages into differentiated SH-SY5Y cells stably transfected with the wild-type alpha-synuclein gene.
• Quantified intracellular AS oligomers using Western blot and ELISA.

Main Results:

• Phage treatment led to reduced levels of soluble alpha-synuclein aggregates in treated cells compared to controls.
• Demonstrated successful internalization of engineered phages into mammalian neuronal cells.
• Confirmed the conformational similarity between filamentous phages and amyloid fibrils.

Conclusions:

• Filamentous phages can modulate alpha-synuclein aggregation, offering a potential new therapeutic avenue for Parkinson's disease.
• Phage-based strategies show promise for targeting intracellular protein aggregation in neurodegenerative diseases.
• Further research into phage therapy for neurodegenerative conditions is warranted.